Wei‐Xiang Qi

Preoperative pembrolizumab combined with chemoradiotherapy for oesophageal squamous cell carcinoma (PALACE-1)

Chengqiang Li, Shengguang Zhao, Yuyan Zheng et al. · European Journal of Cancer · 2020 · 303 citations

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +6

CD133 expression predicts lung metastasis and poor prognosis in osteosarcoma patients: A clinical and experimental study

Aina He, Wei‐Xiang Qi, Yujing Huang et al. · Experimental and Therapeutic Medicine · 2012 · 53 citations · Full text

A first in-human study of A166 in patients with locally advanced/metastatic solid tumors which are HER2-positive or HER2-amplified who did not respond or stopped responding to approved therapies.

Yongheng Liu, Wei Lian, Xi Zhao et al. · Journal of Clinical Oncology · 2020 · 48 citations

Breast Oncology, First In-human Study, Cancer Management +17

p21‐activated kinase 7 is an oncogene in human osteosarcoma

Kun Han, Yan Zhou, Zhihua Gan et al. · Cell Biology International · 2014 · 32 citations · Full text

Osteosarcoma Tissue, Oncogenic Agent, P21-activated Kinase 7 +12

Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort

Wei‐Xiang Qi, Xiaoyan Wang, Chengqiang Li et al. · Thoracic Cancer · 2023 · 29 citations · Full text